13F HOLDINGS REPORT
B Group, Inc.
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001420506-25-000436
Total Value
$163.6M
Positions
18
Other Managers
0
Confidential Omitted
No
Holdings (18)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | INVESCO QQQ TR | IVZ | 110,000 | $56.2M | 34.37% |
| 2 | ADMA BIOLOGICS INC | ADMA | 2,287,542 | $39.2M | 23.98% |
| 3 | INSMED INC | INSM | 350,000 | $24.2M | 14.77% |
| 4 | ZAI LAB LTD | ZLAB | 400,000 | $10.5M | 6.40% |
| 5 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 992,000 | $7.3M | 4.49% |
| 6 | AKERO THERAPEUTICS INC | 00973Y108 | 260,000 | $7.2M | 4.42% |
| 7 | CELLECTIS S A | CLLS | 3,081,501 | $5.5M | 3.39% |
| 8 | AURA BIOSCIENCES INC | AURA | 472,576 | $3.9M | 2.37% |
| 9 | SIGHT SCIENCES INC | SGHT | 629,370 | $2.3M | 1.40% |
| 10 | TAYSHA GENE THERAPIES INC | TSHA | 965,556 | $1.7M | 1.02% |
| 11 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 29,500 | $1.2M | 0.76% |
| 12 | SPYRE THERAPEUTICS INC | SYRE | 50,000 | $1.2M | 0.71% |
| 13 | ASSEMBLY BIOSCIENCES INC | ASMB | 50,651 | $799,273 | 0.49% |
| 14 | APOGEE THERAPEUTICS INC | APGE | 15,000 | $679,500 | 0.42% |
| 15 | CORVUS PHARMACEUTICALS INC | CRVS | 100,000 | $535,000 | 0.33% |
| 16 | BIONTECH SE | BNTX | 3,500 | $398,825 | 0.24% |
| 17 | ORUKA THERAPEUTICS INC | ORKA | 20,000 | $387,800 | 0.24% |
| 18 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 7,596 | $319,564 | 0.20% |